Handelsavisen
prelaunch
Companies Healthcare 363250.KQ
36
363250.KQ KOSDAQ Medical Equipment, Supplies & Distribution

363250.Kq

$3 865,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
26,4B KRW
P/E
EV / Rev
Div yield
Op margin
-4 186,4 %
ROE
-152,2 %
Net margin
-3 135,0 %
Debt / equity
0,52
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.

Business. The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-152,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 363250.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 363250.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. Its liquidity position is marked by a current ratio of 1.08, suggesting a relatively balanced short-term liquidity profile. However, the company's cash and equivalents amount to 1,112,357,400 KRW, which is insufficient to cover its long-term debt of 4,045,388,720 KRW, resulting in a negative net cash position. The price-to-book ratio of 3.63 suggests that the market is valuing the company's equity at a premium relative to its book value.

    Profitability metrics reveal a challenging financial situation. The company reported a net loss of 11,955,428,780 KRW, with a return on equity of -1.5225 and a return on assets of -0.8305, both significantly below the industry median for medical equipment and supplies distribution. The gross profit of -2,464,888,030 KRW and operating income of -15,965,120,140 KRW further underscore the company's operational inefficiencies.

    The company's revenue is not segmented by geographic regions or product lines in the available data, making it difficult to assess the concentration of its revenue sources. However, the negative net cash position and high debt levels suggest a potential risk of over-reliance on a single market or product line.

    The company's growth trajectory is currently negative, with a net loss and declining operating cash flow. The operating cash flow of -6,883,494,030 KRW and free cash flow of -13,985,073,660 KRW indicate a significant outflow of cash, which could hinder future growth initiatives. The capital expenditure of -334,284,810 KRW suggests that the company is not investing in new projects or infrastructure, which may further limit its growth potential.

    The company faces several risk factors, including a negative net cash position and a high debt-to-equity ratio. The risk assessment indicates a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag that could impact the company's ability to meet its short-term obligations. The dilution risk is low, but the company's financial performance and liquidity position could change if it needs to raise additional capital through equity issuance.

    Recent events and filings do not provide specific details on the company's strategic initiatives or financial performance. The company's financial snapshot indicates a challenging operating environment, with significant losses and negative cash flows. The lack of detailed information on recent events or strategic moves makes it difficult to assess the company's future direction.

    Key takeaways
    • The company is operating in a loss-making position with a net loss of 11,955,428,780 KRW.
    • The company's liquidity position is moderate, with a current ratio of 1.08 and a negative net cash position.
    • The company's profitability metrics are significantly below the industry median, indicating operational inefficiencies.
    • The company is not investing in new projects or infrastructure, as indicated by the capital expenditure of -334,284,810 KRW.
    • The company faces a medium liquidity risk and a low dilution risk, but its financial performance could change if it needs to raise additional capital.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $3 865,00
    Market cap
    $28.51B
    Enterprise value
    $31.44B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    3.6x
    P / Tangible book
    3.6x
    Tangible book
    $7.85B
    Net cash
    -$2.93B
    Current ratio
    1.1
    Debt / equity
    0.5
    ROA
    -83.0%
    ROE
    -1.5%
    Cash conversion
    58.0%
    CapEx / revenue
    -87.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-4 186,4 %Bottom quartile
    Net Margin-3 135,0 %Bottom quartile
    ROE-152,2 %Bottom quartile
    Capex / Rev-87,7 %Bottom quartile
    D/E0,52Bottom quartile
    Cash Conv0,58Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • 363250.KQ Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    363250.KQCanonical
    KOSDAQ · KRW

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage